Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Somatropin
Drug ID BADD_D02055
Description Human growth hormone (HGH), also known as somatotropin, is a peptide hormone that is synthesized and secreted by the somatotropic cells of the anterior pituitary gland.[A228183] Growth hormone plays an essential role in growth regulation during childhood as well as other basal metabolic functions, muscle and fat mass regulation, blood glucose level regulation, and lipid regulation in both children and adults.[A228183, L31508] Synthesized in a strain of _Escherichia coli_, recombinant HGH is a polypeptide hormone that contains 191 amino acid residues with a molecular weight of 22 kDa. It has an identical primary protein structure to endogenous human growth hormone.[A228188] Recombinant HGH has been commercially available since 1985 after its development by Genentech. [Somatrem] was the first available recombinant HGH and was largely replaced by somatropin, another form of recombinant HGH.[A228183] Growth hormone therapy is approved for various disorders of growth hormone deficiency, growth failure, or short stature including Turner syndrome, chronic renal insufficiency before transplantation, Prader-Willi syndrome, a history of fetal growth restriction, short stature homeobox (SHOX) haploinsufficiency, Noonan syndrome, idiopathic short stature, and adult- or childhood-onset growth hormone deficiency.[A228188] Recombinant growth hormone is available as a subcutaneous injection for children and adults under a wide variety of brand names.
Indications and Usage For treatment of dwarfism, acromegaly and prevention of HIV-induced weight loss
Marketing Status Prescription; Discontinued
ATC Code H01AC01
DrugBank ID DB00052
KEGG ID D02691
MeSH ID D019382
PubChem ID Not Available
TTD Drug ID D09DMQ
NDC Product Code 55566-1902; 44087-0004; 62287-190; 44087-0006; 55566-1901; 0002-8149; 50242-075; 0013-2655; 0013-2626; 44087-3388; 68594-040; 0002-8148; 0002-8147; 0013-2650; 0169-7705; 0781-4004; 0013-2653; 0013-2649; 0013-2658; 50242-076; 0013-2646; 0013-2656; 50242-074; 44087-0005; 0781-3001; 44087-1005; 55566-1801; 44087-0016; 0013-2652; 0169-7708; 50242-931; 0013-2654; 0013-2651; 0169-7704; 0781-3004; 44087-1088; 0013-2657; 0169-7703; 57831-0423
Synonyms Human Growth Hormone | Growth Hormone, Human | hGH (Human Growth Hormone) | Somatropin (Human) | Somatotropin (Human) | Somatropin | Serostim | Zomacton | Cryo-Tropin | Cryo Tropin | CryoTropin | Recombinant Human Growth Hormone (Mammalian) | r-hGH-M | r-hGH(m) | Humatrope | Umatrope | Maxomat | Norditropin | Norditropin Simplexx | Norditropine | Nutropin | Omnitrope | Saizen | Genotropin | Genotonorm
Chemical Information
Molecular Formula Not Available
CAS Registry Number 12629-01-5
SMILES Not Available
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal distension07.01.04.001--
Abdominal pain07.01.05.002--
Alopecia23.02.02.001--
Arthralgia15.01.02.001--
Arthritis15.01.01.001--
Arthropathy15.01.01.003--Not Available
Back pain15.03.04.005--
Breast enlargement21.05.04.001--Not Available
Breast pain21.05.05.003--
Bronchospasm22.03.01.004; 10.01.03.012--
Bursitis15.04.01.001--Not Available
Chest pain08.01.08.002; 02.02.02.011; 22.02.08.003--Not Available
Chills15.05.03.016; 08.01.09.001--
Constipation07.02.02.001--
Crohn's disease10.02.01.005; 07.08.01.015--Not Available
Dehydration14.05.05.001--
Depression19.15.01.001--
Dermatitis bullous23.03.01.002--
Dizziness24.06.02.007; 17.02.05.003; 02.01.02.004--
Dry mouth07.06.01.002--
Dyspnoea22.02.01.004; 02.01.03.002--
Dysuria20.02.02.002--
Ear disorder04.03.01.001--Not Available
Face oedema23.04.01.004; 10.01.05.002; 08.01.07.003--
Fatigue08.01.01.002--
Flatulence07.01.04.002--
Fungal infection11.03.05.001--Not Available
Gastric ulcer07.04.03.002--
Gastrointestinal fistula07.11.05.001--
Generalised oedema14.05.06.007; 08.01.07.004--
The 1th Page    1 2 3    Next   Last    Total 3 Pages